• No results found

PATIENTS TREATED WITH PLACEBO/

A comparative study of the treatment outcomes in Alcoholic Liver Disease patients treated with Ursodeoxycholic acid and Methionine along with Abstinence (Placebo)

A comparative study of the treatment outcomes in Alcoholic Liver Disease patients treated with Ursodeoxycholic acid and Methionine along with Abstinence (Placebo)

... Keywords: Alcoholic liver disease, ursodeoxycholicacid, S-Adenosyl Methionine SGOT, SGPT, INR, Prothrombin. Article Info: Received 25 March 2019; Review Completed 06 May 2019; Accepted 09 May 2019; Available online 15 ...

8

Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical study

Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical study

... older patients experiencing a major depressive disorder or other comorbid diseases, or to ...only patients willing and able to follow the study protocol were assessed, so a positive selection bias cannot be ...

6

Effects on health related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials

Effects on health related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials

... in patients with bipolar depression ...in patients with bipolar disorder [34, ...Bipolar patients with depression had significantly lower HRQoL scores in comparison to recovered, recovering, and ...

9

Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial

Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial

... those patients, even in the absence of an absolute weight ...in patients with antipsychotic treatment have often proven to be dif fi cult and may be without pro- nounced or sustained ...some patients, ...

8

Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies

Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies

... Results: Patients treated with omalizumab reported a larger reduction in sleep problems than those in the placebo arm; omalizumab 300 mg demonstrated the greatest improvement on all sleep components ...

10

Treated Patients Biochemical Studies on the Hepatotoxicity of Atorvastatin

Treated Patients Biochemical Studies on the Hepatotoxicity of Atorvastatin

... in patients with multiple risk factors for coronary heart ...14,236 patients treated for an average period of 2 weeks to 52 months was ...and placebo (n = 2,180) and included analyses on ...

22

Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials

Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials

... for every two patients treated with a GLP-1 RA, one will meet the < 7% A 1C target within 6 months. Compared to direct evidence from head-to-head studies, evidence generated from this NMA allows for a more ...

12

Human herpes virus antibody levels in helminth treated and placebo controlled multiple sclerosis patients

Human herpes virus antibody levels in helminth treated and placebo controlled multiple sclerosis patients

... of patients with multiple sclerosis were published ...of patients were RRMS with some SPMS; however, for the purposes of the (our) study reported here the breakdown by clinical phenotype is not yet ...

124

Sleep architecture and cognitive changes in olanzapine treated patients with depression: A double blind randomized placebo controlled trial

Sleep architecture and cognitive changes in olanzapine treated patients with depression: A double blind randomized placebo controlled trial

... There are a number of limitations in this study. First, participants were maintained on a large variety of concomitant medications. This likely contributed to the highly variable effect of olanzapine on SWS. Secondly, ...

11

Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo controlled trial

Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo controlled trial

... for patients to be included in this ...to patients with some psychiatric comorbid disorders or unstable medical or comorbid pain disorders or to patients who were treatment-refrac- tory or disabled, ...

8

Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis

Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis

... COPD is a multi-component disease, associated with inflammation, airway obstruction, mucociliary dysfunc- tion and structural changes in the lung. Consequently, it is logical to assume that interventions addressing these ...

10

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials

... of patients who met specific thresholds for global ...adult patients with MDD, this analytic approach may offer clinicians a practical method for evaluating antidepressant efficacy in clinical ...

9

Serum biomarkers and changes in clinical/MRI evidence of golimumab treated patients with ankylosing spondylitis: results of the randomized, placebo controlled GO RAISE study

Serum biomarkers and changes in clinical/MRI evidence of golimumab treated patients with ankylosing spondylitis: results of the randomized, placebo controlled GO RAISE study

... short placebo period complicates inter- pretation of “placebo group” imaging data at weeks 104 and ...few patients on whom to base correlation analyses for radiographic progression and development of ...

7

Heparin binding protein in patients with acute respiratory failure treated with granulocyte colony stimulating factor (filgrastim) – a prospective, placebo controlled, double blind study

Heparin binding protein in patients with acute respiratory failure treated with granulocyte colony stimulating factor (filgrastim) – a prospective, placebo controlled, double blind study

... to patients with local infections only, but not compared to febrile patients who develop septic shock or severe ...in placebo group rather than an in- crease in HBP –concentrations of filgrastim ...

6

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-controlled study

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-controlled study

... memantine patients, such as those accounting for the decision not to try a cholinesterase inhibitor in the large majority, could have accounted for the failure to respond to ...these patients had “probable ...

10

Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis

Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis

... 641 patients (326 treated with ¯umazenil and 315 with placebo), were ...of patients with clinical improvement (®ve trials) were 27% in treated groups and 3% in placebo ...

12

Diabetic patients treated with insulin,

Diabetic patients treated with insulin,

... Many patients will be forced to throw out unfinished bottles of ...Do patients covered by prescription plans get enough insulin bottles to abide by the manufacturers’ recommendations or do they calculate ...

5

Whiplash patients who are treated

Whiplash patients who are treated

... Ten years ago population health experts thought they knew some of the answers, says Frank, a Professor in the Department of Public Health Sciences at the University of Toronto and Scient[r] ...

8

treated and 64 untreated patients

treated and 64 untreated patients

... Megavoltage radiotherapy by an off axis beam rotational technique (12 patients, with preceding surgery in eight) abolished pain and dyspnoea and may have prolonged survival in one patien[r] ...

5

A Comparison of Clinical Characteristics between Medically-treated Patients and Surgically-treated Patients with Ischemic Colitis

A Comparison of Clinical Characteristics between Medically-treated Patients and Surgically-treated Patients with Ischemic Colitis

... that patients with DM took sta- tistically longer time before ...ESRD patients on hemodialysis showed severe clinical course re- quiring surgical treatment and longer mean time to admis- ...IC ...

6

Show all 10000 documents...

Related subjects